C. Alagona

Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease

L. Spadaro, O. Magliocco, Daniela Spampinato et al. · Digestive and Liver Disease · 2007 · 293 citations

Metabolic Syndrome, Hepatology, Nonalcoholic Fatty Liver Disease +10

Decreased High-Density Lipoprotein (HDL) Particle Size, Preβ-, and Large HDL Subspecies Concentration in Finnish Low-HDL Families

Hiroshi Watanabe, Sanni Söderlund, Aino Soro‐Paavonen et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2006 · 69 citations · Full text

Therapeutic options for elderly diabetic subjects: open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs

Giuseppe Francesco Sferrazza Papa, Viviana Fedele, A. Chiavetta et al. · Acta Diabetologica · 2008 · 40 citations

Diabetes Management, Open Label, Geriatrics +9

A low high density lipoprotein (HDL) level is associated with carotid artery intima-media thickness in asymptomatic members of low HDL families

C. Alagona, Aino Soro, Kati Ylitalo et al. · Atherosclerosis · 2002 · 39 citations

Metabolic Syndrome, Vascular Disease, Low Hdl Families +11

Effects of Either LT4 Monotherapy or LT4/LT3 Combined Therapy in Patients Totally Thyroidectomized for Thyroid Cancer

Concetto Regalbuto, Raffaella Maiorana, C. Alagona et al. · Thyroid · 2007 · 32 citations

Neuro-oncology, Thyroid Function, Medicine +14